Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

66.18 0.40 −0.60%
Market cap
$32.1B
P/E
50.5×
Fwd P/E
31.0×
Dividend yield
0.53%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

35.15 39.60 45.12 51.22
P/S ratio
3.61 3.74 3.45 3.01
P/FCF ratio
26.53 24.10 23.00 20.49
P/Operating CF
50.76 59.07 87.82 64.03
P/B ratio
1.66 1.76 1.66 1.51
Price to Tangible BV
10.04 10.30 9.18 8.03
EV/Sales
3.93 4.04 3.74 3.31
EV/EBITDA
15.31 16.46 15.67 13.13
EV/Operating CF
19.30 18.49 17.26 15.55
EV/FCF
28.87 26.04 24.93 22.53
Quick Ratio
1.15 1.17 1.22 1.12
Current Ratio
2.12 2.12 2.20 2.09
Net Debt/EBITDA
4.89 4.85 4.93 4.06
Debt/Assets
15.01% 15.01% 14.97% 15.17%
Debt/Equity
0.21 0.22 0.21 0.22
Asset Turnover
0.33 0.34 0.34 0.35
Operating CF/Net income
3.05 3.03 2.21 0.00
Capex/Depreciation
(0.56) (0.61) (0.58) (0.18)
Interest Coverage
6.51 5.91 5.62 0.21
Research and Development Expense of Revenue
9.56% 10.04% 9.05% 23.49%
Selling, General and Administrative Expense of Revenue
33.09% 33.15% 32.59% 34.15%
Intangible Assets out of Total Assets
0.58 0.58 0.57 0.56
Share Based Compensation of Revenue
1.57% 1.62% 1.66% 1.49%
Graham Net Nets
(0.08) (0.08) (0.08) (0.09)
Graham Number
46.22 44.73 41.32 36.16
Earnings Yield
2.85% 2.53% 2.22% 1.95%
Free Cash Flow Yield
3.77% 4.15% 4.35% 4.88%
Revenue per Share
5.30 5.51 5.55 5.80
Operating CF per Share
1.47 1.33 0.86 1.05
Capex per Share
(0.37) (0.41) (0.39) (0.29)
Free Cash Flow per Share
1.09 0.93 0.47 0.76
Cash per Share
3.04 3.26 3.41 2.99
Shareholders Equity per Share
44.79 44.68 45.43 44.37
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
44.79 44.68 45.43 44.37
Free Cash Flow
540.00 457.00 227.00 370.00
Working Capital
3,343.00 3,400.00 3,616.00 3,457.00
Capital Expenditures
(184.00) (201.00) (191.00) (140.00)
Net Current Asset Value
(3,103.00) (3,071.00) (2,866.00) (2,878.00)
EV/EBIT
27.73 30.88 33.60 37.89
Capex to Sales
0.07 0.07 0.07 0.05
Price to Operating Income
25.48 28.58 31.01 34.45
Other line items
Average Receivables
1,853.50 1,860.50 1,933.50 2,057.50
Average Payables
872.00 849.50 880.50 931.50
Average Inventory
2,405.50 2,329.50 2,390.50 2,452.00
Average Assets
30,943.00 30,951.00 31,313.50 31,242.50
Average Common Equity
21,738.50 21,794.00 22,076.00 21,863.00

Fold the line items

Columns are period end dates